Merck’s COVID-19 pill could pose risks during pregnancy: report

While the Food and Drug Administration (FDA) is expected to soon rule on whether to authorize Merck's COVID-19 pill, questions remain regarding its risks in pregnant women.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.